NASDAQ:ADRO - Aduro BioTech, Inc.
$3.38
 $-0.03
-0.88%
4:00PM EDT
2019-04-18
Aduro Biotech, Inc. is an immunotherapy company, which focuses on the discovery, development and commercialization of therapies that manage the treatment of various diseases, including cancer. The Company's product candidates from its Live, Attenuated, Double-Deleted (LADD) Listeria monocytogenes, Stimulator of Interferon Genes Pathway Activator, and B-select monoclonal antibody platforms are designed to stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies, as well as other immunotherapies. Its LADD technology platform is being developed as a treatment for multiple indications, including mesothelioma, ovarian, gastric, lung and prostate cancers. Its LADD product candidate is CRS-207, which is being developed as a treatment for multiple indications, including mesothelioma, ovarian and gastric cancers. ADU-214 and ADU-741 are product candidates in development for lung and prostate cancers, respectively. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  ADRO     avg for
industry  
  avg for
sector  
42 stocks weight:  0. 45   199. 07   233. 87  
42 stocks rank:  3. 92 K 1. 43 K 1. 06 K
# analyst opinions:  4. 00   14. 48   14. 09  

quick ratio:  9. 12   5. 29   1. 92  
current ratio:  9. 27   5. 64   2. 40  

target price low:  4. 00   84. 50   115. 74  
target price avg:  7. 00   110. 73   137. 39  
target price high:  10. 00   136. 41   157. 80  
1-yr high:  8. 80   114. 11   138. 85  
last close:  3. 38   87. 56   116. 78  
50-day avg:  3. 88   95. 43   123. 53  
200-day avg:  4. 58   94. 13   121. 20  
1-yr low:  2. 42   72. 67   98. 41  
volume:  196. 86 K 2. 43 M 4. 85 M
50-day avg volume:  466. 97 K 2. 72 M 4. 97 M
200-day avg volume:  628. 77 K 2. 90 M 4. 58 M

1-day return:  -0. 88 % -0. 40 % 0. 07 %
this week return:  -7. 90 % -5. 72 % -4. 11 %
12-wk return:  28. 03 % 1. 78 % -0. 04 %
52-wk return:  -49. 73 % 10. 81 % 14. 09 %

enterprise value (EV):  26. 09 M 51. 19 B 117. 96 B
market cap:  269. 90 M 43. 00 B 104. 52 B
EBITDA:  -92. 42 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  -0. 28   4. 34   13. 27  
enterprise/revenue (EV/R):  1. 73   68. 16   13. 68  
total revenue:  15. 09 M 10. 61 B 38. 24 B
total debt:  0. 00   12. 22 B 16. 66 B
net income (common):  -95. 36 M 2. 20 B 4. 21 B

shares outstanding:  79. 85 M 570. 91 M 1. 24 B
shares:  50. 78 M 571. 02 M 1. 23 B
shares short:  1. 50 M 9. 93 M 16. 79 M
shares short prior month:  1. 60 M 9. 96 M 16. 58 M
short ratio:  2. 19   5. 31   3. 30  
short % of float:  2. 84 % 5. 81 % 2. 61 %
total cash/share:  3. 34   11. 13   9. 30  
total cash:  266. 44 M 6. 70 B 7. 10 B
free cash flow:  -44. 19 M 3. 58 B 4. 74 B
operating cash flow:  -68. 76 M 4. 14 B 6. 32 B

book value:  1. 70   12. 76   26. 84  
price/book:  1. 99   3. 08   -1. 74  
gross profits:  15. 09 M 8. 03 B 34. 77 B
operating margins:  -645. 38 % -721. 97 % -88. 82 %
EBITDA margins:  0. 00 % 10. 94 % 22. 54 %
profit margins:  0. 00 % 7. 81 % 10. 60 %
gross margins:  0. 00 % 37. 02 % 55. 68 %

1-yr max volatility:  -29. 46 % --- ---
1-yr mean volatility:  -0. 16 % 0. 03 % 0. 04 %

1-yr EPS:  -1. 21   2. 39   4. 08  
forward EPS:  -0. 83   3. 97   7. 14  
P/E:  -2. 79   13. 59   22. 83  
forward P/E:  -4. 42   -20. 05   14. 49  
PE/G:  0. 11   -1. 46   1. 68  
growth:  -26. 60 % 126. 81 % 29. 29 %
earnings high:  -0. 11   1. 02   1. 63  
earnings avg:  -0. 22   0. 76   1. 51  
earnings low:  -0. 27   0. 47   1. 39  
revenue high:  15. 02 M 2. 68 B 10. 71 B
revenue avg:  7. 34 M 2. 59 B 10. 49 B
revenue low:  2. 75 M 2. 49 B 10. 25 B
return on assets:  -15. 16 % -2. 80 % 5. 29 %
return on equity:  -51. 16 % -18. 52 % 7. 38 %
revenue growth:  -26. 60 % 92. 55 % 19. 15 %
revenue/share:  0. 19   13. 27   55. 24  

beta (1yr vs S&P500):  0. 83   1. 24   0. 93  
sharpe (1yr):  -0. 50   0. 29   0. 60  

held % insiders:  43. 11 % 6. 38 % 3. 38 %
held % institutions:  42. 79 % 78. 60 % 68. 65 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-19 : ADRO
.    + 0.628 =         0.628 :: INITIAL WEIGHT
.   + 44.891 =         45.52 :: spline projection addition
.    x 1.432 =        65.185 :: industry recommendation factor
.    x 1.025 =         66.84 :: EV/R factor
.    x 0.998 =        66.738 :: return on assets factor
.    x 0.995 =        66.397 :: return on equity factor
.    x 0.997 =         66.22 :: revenue growth factor
.    x 2.355 =       155.975 :: current ratio factor
.     x 1.06 =       165.295 :: quick ratio factor
.    x 1.207 =       199.496 :: short ratio factor
.     x 2.02 =       402.958 :: price-to-book factor
.    x 2.129 =       857.779 :: P/E weight
.    x 1.757 =      1506.826 :: PE/G factor
.    x 1.614 =      2431.876 :: beta factor
.    x 0.501 =      1217.838 :: sharpe factor
.     x 1.44 =      1754.288 :: target low factor
.    x 1.345 =      2359.456 :: target mean factor
.     x 1.14 =       2689.66 :: target high factor
.    x 1.312 =      3527.888 :: industry 2-weeks return factor
.    x 0.952 =      3357.337 :: "drift" penalty 1 days ago
.    x 0.935 =      3137.716 :: "drift" penalty 2 days ago
.    x 0.971 =      3045.268 :: "drift" penalty 3 days ago
.    x 0.902 =      2747.748 :: "drift" penalty 4 days ago
.    x 0.854 =      2345.873 :: overall "drift" factor
.    x 0.999 =      2342.869 :: largest single-day jump factor
.    x 0.072 =       169.773 :: low price factor
.      x 1.0 =       169.746 :: factor hist industry gain for week 15
.   cubeRoot =         5.537 :: reduced to standardize
.   - 24.869 =         0.454 :: add/subtract for performance
.                      0.454 :: FINAL WEIGHT for NASDAQ:ADRO


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org